RegeneRx Biopharmaceuticals, Inc. (NYSEMKT:RGN)

CAPS Rating: No stars

The Company is a biopharmaceutical company that focuses on the discovery and development of novel molecules to accelerate tissue and organ repair.

Results 1 - 1 of 1
Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
tomei69147 85.93 6/13/2007 Underperform 1Y $2.13 -89.08% +45.86% +134.94 0 Comment
Results 1 - 1 of 1

Featured Broker Partners


Advertisement